Skip to content

To investigate the effect of aromatherapy on reperfusion injury protection and long-term prognosis after STEMI intervention: a prospective, randomized controlled study

To investigate the effect of aromatherapy on reperfusion injury protection and long-term prognosis after STEMI intervention: a prospective, randomized controlled study

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000031950
Enrollment
Unknown
Registered
2020-04-15
Start date
2020-05-01
Completion date
Unknown
Last updated
2021-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute myocardial infarction

Interventions

Sponsors

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of TCM
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Voluntarily participate in the study and sign the informed consent; 2. Patients with acute ST elevation myocardial infarction; 3. Direct PCI indications; 4. Aged 20 to 80 years.

Exclusion criteria

Exclusion criteria: 1. Chest pain symptoms > for 12 hours; 2. Severe hypotension or cardiogenic shock that cannot be corrected by optimized medication; 3. Successful thrombolysis ; 4. Platelet (PLT) 110 umol/L; Uric acid > 0.42mol/L; Heart rate = 24kg/m2; Male weight < 50Kg; Female weight < 40Kg; 5. History of other myocardial infarction in the past 5 weeks; 6. The condition was unable to complete PCI; 7. Pregnant and nursing women; 8. Participated in other clinical trials within the past 1 month; 9. Not suitable for participants.

Design outcomes

Primary

MeasureTime frame
CTFC;

Secondary

MeasureTime frame
CK, CK-M, cTnI;ST-segment resolution;MACE;

Countries

China

Contacts

Public ContactMin Fan

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of TCM

fanmin@medmail.com.cn+86 13564528699

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026